Allogene Therapeutics Inc
ALLO
Market Cap$369.35M
Close$
$-0.08
106.8% downside
Current Fair Value
106.8% downsideOvervalued by 106.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $369.35 Million |
|---|---|
| Enterprise Value | $384.89 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.32 |
| Beta | 0.99 |
| Outstanding Shares | 210,572,295 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.39 |
|---|---|
| PEG | -17.12 |
| Price to Sales | - |
| Price to Book Ratio | 0.59 |
| Enterprise Value to Revenue | 8950.9 |
| Enterprise Value to EBIT | -1.38 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
ESG Score
No data